home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

Maximizing Therapeutic Success in Rare Diseases through Basket & Umbrella Trial Designs

 
  January 30, 2025  
     
 
Xtalks, Online
2025-02-20



Basket and umbrella protocol designs are becoming more prevalent in rare disease clinical trials because they can offer significant benefits in the development process; however, they also introduce challenges necessitating strategic planning and careful execution.

The diverse presentation of rare diseases complicates the standardization of endpoints, and the subjective nature of some clinical outcomes may lead to varied interpretations by different investigators. This webinar will examine the strategic advantages and statistical considerations or benefits of choosing either a basket or an umbrella trial design, including increased research efficiencies and the ability to explore multiple therapies or rare diseases within a single trial structure.

The team will also explore adaptive medical monitoring strategies that are crucial in supporting master protocol frameworks while ensuring the trial remains flexible and responsive to emerging data, enhancing the potential for success across various treatment arms.

Furthermore, effective management practices for multi-arm clinical trials will be explained, from logistical considerations to ethical implications, with an emphasis on optimizing patient recruitment and efficient data collection methods, ensuring that each trial phase is conducted with precision and in accordance with regulatory standards.

Attendees will gain a deeper understanding of how these advanced trial designs can be utilized not only to accelerate the development of therapies for rare diseases but also to address challenges and pave the way for improved patient outcomes.

Register for this webinar to discover how basket and umbrella trial designs are transforming rare disease clinical research.

Keywords: Drug Development, Clinical Research, Trial Design, CRO, Clinical Data, Adaptive Trial Design, Clinical Trial Design, Basket Trials, Umbrella Trials, Rare Diseases/Orphan Drugs
 
 
Organized by: Xtalks
Invited Speakers: Maria-Cruz Morillo, Global Head, Allucent Rare Disease Center of Expertise
Milan Marinkov, Executive Medical Director, Rare Disease Medical Lead, Allucent
Genevieve Wills, Associate Director, Biostatistical Consulting, Allucent
 
Deadline for Abstracts: 2025-02-20
 
Registration: Free Registration
E-mail: tristan@xtalks.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2025 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.